4.6 Review

Regulating the regulator: negative regulation of Cbl ubiquitin ligases

Journal

TRENDS IN BIOCHEMICAL SCIENCES
Volume 31, Issue 2, Pages 79-88

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibs.2005.12.004

Keywords

-

Funding

  1. Intramural NIH HHS Funding Source: Medline

Ask authors/readers for more resources

Cbl proteins are regulators of signal transduction through many pathways and, consequently, regulate cell function and development. They are ubiquitin ligases that ubiquitinate and target many signaling molecules for degradation. The Cbl proteins themselves are regulated by an increasingly complex network of interactions that fine-tune the effects that Cbl proteins have on signaling. The negative regulation of Cbl protein function can occur via cis-acting structural elements that prevent inappropriate ubiquitin ligase activity, degradation of the Cbl proteins, inhibition without degradation owing to interaction with other signaling proteins, deubiquitination of Cbl substrates, and regulation of assembly of the endosomal ESCRT-I complex. Defects in the regulatory mechanisms that control Cbl function are implicated in the development of immunological and malignant diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available